/TSTS

TSTS Stock - That Marketing Solution, Inc.

Q: What is the analyst price target for TSTS?

Analyst price target information is not currently available for TSTS.

Q: What is TSTS's market cap?

Market capitalization information is not currently available for TSTS.

Healthcare|Medical - Pharmaceuticals|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TSTS

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2013

FY2014

FY2015

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta8.85

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2015	FY2014	FY2013
Revenue	$495	N/A	N/A
Gross Profit	$-20,421	N/A	N/A
Gross Margin	-4125.5%	N/A	N/A
Operating Income	$-290,025	$-54,683	$-15,350
Net Income	$-787,146	$-54,775	$-15,350
Net Margin	-159019.4%	N/A	N/A
EPS	$-0.00	$-0.00	$-0.00

Company Overview

That Marketing Solution, Inc., a development stage company, focuses on the development, manufacturing, advertising, sale, and marketing of nutritional products. It acquired the rights to a proprietary formula for a blend of nutritional supplements called Low-T capsules that are intended to be a natural, non-FDA regulated, and over-the-counter supplement, which addresses the primary contributing factors of decreased levels of testosterone in males over the age of 30. The company was formerly known as Vista Holding Group, Corp. and changed its name to That Marketing Solution, Inc. in September 2014. That Marketing Solution, Inc. was founded in 2012 and is based in Salt Lake City, Utah.

Visit Website

Frequently Asked Questions about TSTS

What is TSTS's current stock price?

That Marketing Solution, Inc. (TSTS) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for TSTS?

No analyst price targets are currently available for this stock.

What sector is That Marketing Solution, Inc. in?

That Marketing Solution, Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.

What is TSTS's market cap?

That Marketing Solution, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does TSTS pay dividends?

No, That Marketing Solution, Inc. does not currently pay a dividend to shareholders.